Abstract:Objective To study dynamic expression of Oct-4 during development of colorectal cancer (CRC) and investigate the association between Oct-4 expression and prognosis of patients with CRC.Methods CRC tissues, matched non-tumor tissues and colonic polyp tissues were collected and Oct-4 expressions were analyzed by quantitative reverse transcription-polymerase chain reaction (qRT-PCR), flow cytometry analysis (FCM) and immunohistochemistry (IHC).Medical records of patients with CRC were reviewed.Clinicopathological analysis was performed to assess the association between Oct-4 expression and certain chnicopathological parameters.Kaplane-Meier survival curve was conducted to evaluate association between Oct-4 expression and survival time of patients with CRC.Results The results of qRT-PCR showed that the relative expressions of Oct-4 mRNA in matched non-tumor, colonic polyp and CRC tissues were (0.23 ±0.16) × 10-5, (1.19 ± 0.76) × 10-5 and (3.79 ± 1.94) × 10-5 respectively, with a significant difference (F =8.633, P =0.001).IHC analysis displayed that the positive expression ratios of Oct-4 in matched non-tumor tissues, colonic polyp tissues and CRC tissues were 4.43％, 12.68％ and 40.51％ respectively, and a significant difference was discovered among them (x2 =66.311, P ＜ 0.001).Oct-4 expre-ssion in CRC was significantly correlated with pathological stage (x2 =7.248, P =0.007), lymph node metastasis (x2 =4.888, P =0.027), distant metastasis (x2 =5.732, P=0.017) and TNM stage (x2 =4.174, P=0.041).Kaplan-Meier survival curve analysis demonstrated that Oct-4 positive cases had a shorter median survival time (37.0 months) compared with Oct-4 negative cases (76.0 months), with a significant difference (x2 =14.050, P =0.001).Conclusion The expression of Oct-4 is step-wise increased during development of CRC.The abnormal expression of Oct-4 may play certain roles in the development of CRC.Oct-4 may be an important biomarker for the clinical diagnosis, assessment of disease and prognosis in CRC.

Expression of Tcf-4 Mrna in Colorectal Cancer Tissues

T Cell Factor 4 Gene Expression and Mutation in Hepatocellular Carcinoma

Association of Tob Mrna Expression with Clinicopathological Characteristics of Colorectal Cancer

Study on the expression and mutation of hTcf-4 gene in liver cancer cell lines

[High expression of TCF-4 positively correlated with lung cancer progression.].

Association of Htcf—4 Gene Expression and Mutation with Clinicopathological Characteristics of Hepatocellular Carcinoma

Expression of Tob mRNA in Human Colorectal Cancer

Expression of Zinc Finger and BTB Domain-Containing 4 in Colorectal Cancer and Its Clinical Significance.

Correlation of Expression of Oct-4 and Tumorigenesis and Prognosis of Colorectal Cancer

Expression of Thymosin β4 Gene in Human Colorectal Cancer Tissues and its Clinical Significance

Tmprss4 Correlates With Colorectal Cancer Pathological Stage And Regulates Cell Proliferation And Self-Renewal Ability

Genome-wide ChIP-seq analysis of TCF4 binding regions in colorectal cancer cells.

Expression of Oct-4 is Significantly Associated with the Development and Prognosis of Colorectal Cancer.

Clinicopathological and prognostic significance of TM4SF5 in colorectal cancer

High expression level of TMPRSS4 predicts adverse outcomes of colorectal cancer patients

Expression and Splice Variant Analysis of Human TCF4 Transcription Factor in Esophageal Cancer

[Expressions of OCT4 and CD133 and Their Correlation in Colonic Cancer].

Expression of Aquaporin-4 in Human Colorectal Carcinoma

Expression and clinical significance of Transcription factor 4 (TCF4) in epithelial ovarian cancer.

Overexpression of Transcription Factor Activating Enhancer Binding Protein 4 (TFAP4) Predicts Poor Prognosis for Colorectal Cancer Patients.

[The relationship between expressions of β-catenin and TCF-4 in non-small cell lung cancer].